Central Aortic Pressure and Arterial Stiffness in Parkinson's Disease: A Comparative Study

Overview

Journal Parkinsons Dis

Publisher Wiley

Date 2022 Jul 22

PMID 35864933

Authors

Mehmet Balal

Meltem Demirkiran

Saime Paydas

Affiliations

Soon will be listed here.

Abstract

Background: Cardiovascular autonomic dysfunction, which leads to hemodynamic disorders, is commonly observed in patients with Parkinson's disease (PD). Central aortic pressure (CAP) is the systolic blood pressure (SBP) at the root of the aorta. In young people, CAP is lower than peripheral arterial blood pressure. In older people, the difference between CAP and peripheral arterial blood pressure decreases depending on the extent of arterial stiffness (AS). In patients with AS, CAP increases. CAP is thus regarded as an indicator of AS.

Objective: To compare CAP and other hemodynamic parameters for AS between patients with Parkinson's disease and control group. We also aimed to evaluate changes in these hemodynamic parameters after the levodopa (LD) intake.

Methods: We included 82 patients with PD and 76 healthy controls. Age, sex, disease duration, disease subtype, Hoehn-Yahr stage (H&Y), and nonmotor symptoms (NMS) were documented. TensioMed Software v.3.0.0.1 was used to measure CAP, peripheral arterial blood pressure, pulse pressure (PP), heart rate (HR), mean arterial pressure (MAP), augmentation index (AI), pulse wave velocity, and ejection time. All patients were being treated with LD, and measurements were performed 1 h before and 1 h after LD intake.

Results: Baseline peripheral arterial blood pressure and CAP values were significantly higher in the PD group than in the control group ( < 0.001 and =0.02, respectively). Most cardiac hemodynamic parameters, including peripheral arterial blood pressure and CAP, decreased significantly ( < 0.02 and < 0.001, respectively) after LD intake in the PD group. Disease subtype, duration, and severity did not affect any of the hemodynamic parameters. When NMS were evaluated, patients with psychosis and dementia showed higher baseline parameters.

Conclusion: Loss of postganglionic noradrenergic innervation is well-known with PD. Several cardiac hemodynamic parameters were affected, suggesting cardiac autonomic dysfunction in these patients. The data obtained were independent of disease severity, duration, and subtype. After LD intake, most of these parameters decreased, which might have a positive effect on the vascular burden.

Citing Articles

Intrarater Reliability and Agreement of Blood Pressure, Arterial Stiffness, and Heart Rate Variability Assessments in Patients With Parkinson's Disease.

Lima V, Fecchio R, Pimentel Piemonte M, de Almeida Correia M, Kanegusuku H, Ritti-Dias R Arq Bras Cardiol. 2024; 121(10):e20240132.

PMID: 39536196 PMC: 11634208. DOI: 10.36660/abc.20240132.

References

Amino T, Orimo S, Itoh Y, Takahashi A, Uchihara T, Mizusawa H . Profound cardiac sympathetic denervation occurs in Parkinson disease. Brain Pathol. 2005; 15(1):29-34. PMC: 8095848. DOI: 10.1111/j.1750-3639.2005.tb00097.x. View

Williams B, Lacy P, Thom S, Cruickshank K, Stanton A, Collier D . Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006; 113(9):1213-25. DOI: 10.1161/CIRCULATIONAHA.105.595496. View

Laurent S, Kingwell B, Bank A, Weber M, Struijker-Boudier H . Clinical applications of arterial stiffness: therapeutics and pharmacology. Am J Hypertens. 2002; 15(5):453-8. DOI: 10.1016/s0895-7061(01)02329-9. View

Mulders T, van den Bogaard B, Bakker A, Trip M, Stroes E, van den Born B . Arterial stiffness is increased in families with premature coronary artery disease. Heart. 2011; 98(6):490-4. DOI: 10.1136/heartjnl-2011-300999. View

Goldstein D, Holmes C, Bentho O, Sato T, Moak J, Sharabi Y . Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy. Parkinsonism Relat Disord. 2008; 14(8):600-7. PMC: 2650101. DOI: 10.1016/j.parkreldis.2008.01.010. View

Tulba D, Cozma L, Balanescu P, Buzea A, Baicus C, Popescu B . Blood Pressure Patterns in Patients with Parkinson's Disease: A Systematic Review. J Pers Med. 2021; 11(2). PMC: 7918947. DOI: 10.3390/jpm11020129. View

Goldstein D . Dysautonomia in Parkinson's disease: neurocardiological abnormalities. Lancet Neurol. 2003; 2(11):669-76. DOI: 10.1016/s1474-4422(03)00555-6. View

Oh Y, Kim J, Chung Y, You I, Yang D, Chung S . Orthostatic hypotension, non-dipping and striatal dopamine in Parkinson disease. Neurol Sci. 2012; 34(4):557-60. DOI: 10.1007/s10072-012-1176-9. View

Park J, Han S, Baik J . A Comparative Study of Central Hemodynamics in Parkinson's Disease. J Mov Disord. 2017; 10(3):135-139. PMC: 5615173. DOI: 10.14802/jmd.17035. View

10.

Noack C, Schroeder C, Heusser K, Lipp A . Cardiovascular effects of levodopa in Parkinson's disease. Parkinsonism Relat Disord. 2014; 20(8):815-8. DOI: 10.1016/j.parkreldis.2014.04.007. View

11.

Rosenwasser R, Shah N, Smith S, Wen X, Gong Y, Gums J . Baseline predictors of central aortic blood pressure: a PEAR substudy. J Am Soc Hypertens. 2014; 8(3):152-8. PMC: 3959656. DOI: 10.1016/j.jash.2013.12.008. View

12.

Kim J, Oh Y, Lee K, Song I, Park I, Yang D . Carotid artery thickening and neurocirculatory abnormalities in de novo Parkinson disease. J Neural Transm (Vienna). 2014; 121(10):1259-68. DOI: 10.1007/s00702-014-1203-5. View

13.

Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K . Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res. 2002; 25(3):359-64. DOI: 10.1291/hypres.25.359. View

14.

Orimo S, Oka T, Miura H, Tsuchiya K, Mori F, Wakabayashi K . Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy. J Neurol Neurosurg Psychiatry. 2002; 73(6):776-7. PMC: 1757347. DOI: 10.1136/jnnp.73.6.776. View

15.

Kim J, Lee S, Oh Y, Park J, An J, Park S . Cardiovascular Autonomic Dysfunction in Mild and Advanced Parkinson's Disease. J Mov Disord. 2016; 9(2):97-103. PMC: 4886202. DOI: 10.14802/jmd.16001. View

16.

Pierzchlinska A, Kwasniak-Butowska M, Slawek J, Drozdzik M, Bialecka M . Arterial Blood Pressure Variability and Other Vascular Factors Contribution to the Cognitive Decline in Parkinson's Disease. Molecules. 2021; 26(6). PMC: 8001922. DOI: 10.3390/molecules26061523. View

17.

de Simone G, Roman M, Alderman M, Galderisi M, de Divitiis O, Devereux R . Is high pulse pressure a marker of preclinical cardiovascular disease?. Hypertension. 2005; 45(4):575-9. DOI: 10.1161/01.HYP.0000158268.95012.08. View

18.

Goldstein D, Sewell L, Sharabi Y . Autonomic dysfunction in PD: a window to early detection?. J Neurol Sci. 2011; 310(1-2):118-22. DOI: 10.1016/j.jns.2011.04.011. View

19.

Goldstein D, Holmes C, Cannon 3rd R, Eisenhofer G, Kopin I . Sympathetic cardioneuropathy in dysautonomias. N Engl J Med. 1997; 336(10):696-702. DOI: 10.1056/NEJM199703063361004. View

20.

Lee H, Oh B . Aging and arterial stiffness. Circ J. 2010; 74(11):2257-62. DOI: 10.1253/circj.cj-10-0910. View